CVRx, Inc. Net Income (Loss) Available to Common Stockholders, Basic
CVRx, Inc. (CVRX) reported Net Income (Loss) Available to Common Stockholders, Basic of -$43.08 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Income Statement
us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic · last filed 2022-02-22
- CVRx, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-12-31 was -$10.57M.
- CVRx, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-09-30 was -$6.13M.
- CVRx, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-06-30 was -$17.75M.
- CVRx, Inc. net income (loss) available to common stockholders, basic for the quarter ending 2021-03-31 was -$8.63M.
- CVRx, Inc. net income (loss) available to common stockholders, basic for fiscal 2021 was -$43.08M.
- CVRx, Inc. net income (loss) available to common stockholders, basic for fiscal 2020 was -$14.33M.
| Period end | Net Income (Loss) Available to Common Stockholders, Basic 3 month | Net Income (Loss) Available to Common Stockholders, Basic 6 month | Net Income (Loss) Available to Common Stockholders, Basic 9 month | Net Income (Loss) Available to Common Stockholders, Basic 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$16.70M derived: sum of 2 quarters · filed 2022-02-22 | -$34.45M derived: sum of 3 quarters · filed 2022-02-22 | -$43.08M 10-K · filed 2022-02-22 |
| 2021-09-30 | -$6.13M 10-Q · filed 2021-11-08 | -$23.88M derived: sum of 2 quarters · filed 2021-11-08 | -$32.51M 10-Q · filed 2021-11-08 | -$35.91M derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-06-30 | -$17.75M 10-Q · filed 2021-08-09 | -$26.38M 10-Q · filed 2021-08-09 | -$29.78M derived: sum of 3 quarters · filed 2022-02-22 | -$33.22M derived: sum of 4 quarters · filed 2022-02-22 |
| 2021-03-31 | -$8.63M derived: 10-K 12 month − 3 quarters · filed 2022-02-22 | -$12.03M derived: sum of 2 quarters · filed 2022-02-22 | -$15.47M derived: sum of 3 quarters · filed 2022-02-22 | -$19.14M derived: sum of 4 quarters · filed 2022-02-22 |
| 2020-12-31 | -$3.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | -$6.85M derived: sum of 2 quarters · filed 2022-02-22 | -$10.51M derived: sum of 3 quarters · filed 2022-02-22 | -$14.33M 10-K · filed 2022-02-22 |
| 2020-09-30 | -$3.44M 10-Q · filed 2021-11-08 | -$7.11M derived: sum of 2 quarters · filed 2021-11-08 | -$10.92M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | -$3.67M 10-Q · filed 2021-08-09 | -$7.48M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |